Price Alert

Merck & Co. Inc. (MRK)

NYSE: MRK · Real-Time Price · USD

80.40

-1.11 (-1.36%)

At close: Sep 22, 2025, 3:59 PM

80.67

0.34%

Pre-market: Sep 23, 2025, 04:48 AM EDT

-1.36% (1D)

Bid	80.39
Market Cap	200.82B
Revenue (ttm)	63.62B
Net Income (ttm)	16.41B
EPS (ttm)	6.49
PE Ratio (ttm)	12.39
Forward PE	8.46
Analyst	Hold
Dividends	$4.01

Ask	80.45
Volume	8,176,198
Avg. Volume (20D)	13,273,458
Open	81.76
Previous Close	81.51
Day's Range	80.26 - 81.94
52-Week Range	73.31 - 118.16
Beta	0.38
Ex-Dividend Date	Sep 15, 2025

About MRK

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol MRK

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for MRK stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Merck & Co. Inc. is scheduled to release its earnings on Oct 30, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 month ago

-1.7%

Merck & Co shares are trading lower after the comp... Unlock content with Pro Subscription

2 months ago

+2.88%

Merck shares are trading higher after the company announced it will acquire Verona Pharma.

News

1 day ago · zacks.com

Merck (MRK) Stock Sinks As Market Gains: Here's Why

The latest trading day saw Merck (MRK) settling at $80.4, representing a -1.36% change from its previous close.

23 hours ago · zacks.com

Will the FDA's Nod for Subcutaneous Keytruda Ease Merck's Headwinds?

FDA clears MRK's Keytruda Qlex, a subcutaneous option that promises faster treatment and new patent protection amid looming headwinds.

1 day ago · fool.com

3 Dirt-Cheap Stocks to Buy Right Now

The major market indexes are bumping against all-time highs. It's not surprising, therefore, that many stocks are trading at steep valuations.

1 day ago · seekingalpha.com

Merck: Undervalued Pharma Stock With Defensive Approach And Compelling Dividend Yield

Merck trades at 9.09x forward earnings, far below its 23.55x historical multiple and peers, while maintaining strong profitability and a 3.99% dividend yield. Blockbuster drug Keytruda, along with onc...

2 days ago · seekingalpha.com

Undercovered Dozen: Applied Digital, Merck, B2Gold And More

The 'Undercovered' Dozen series highlights 12 lesser-covered stocks weekly, providing investment ideas and sparking community discussion on their potential. Among today's stocks covered are B2Gold, Me...

3 days ago · fool.com

What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill

It is tempting for a dividend investor to simply select the highest yielding stocks. The problem with that approach is that it exposes you to the risk of dividend cuts if the yield is too high for the...

4 days ago · businesswire.com

FDA Approves Merck's KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) Injection for Subcutaneous Use in Adults Across Most Solid Tumor Indications for KEYTRUDA® (pembrolizumab)

RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYT...

4 days ago · reuters.com

US FDA approves Merck's new injectable version of Keytruda

The U.S. Food and Drug Administration has approved a new formulation of Merck's blockbuster cancer therapy Keytruda that can be administered under the skin, offering a more convenient option of the wi...

3 days ago · zacks.com

Can MRK's New Drugs Drive Long-Term Growth Amid Looming Keytruda LOE?

Merck eyes new launches like Capvaxive and Winrevair, among others, to drive long-term growth as Keytruda nears loss of exclusivity.

4 days ago · zacks.com

Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock has in store.

Load More News